文献速递精神分裂症与精神病性障碍

精神分裂症患者多巴胺D2受体内化的PET成像研究

PET imaging of dopamine-D2 receptor internalization in schizophrenia.
PubMed 文献 · Mol Psychiatry · 2017-05-16

本研究采用[11C]raclopride PET成像,在基线及右旋安非他命0.5 mg kg-1后3-5小时和6-10小时,比较10例精神分裂症患者与9例健康对照的纹状体D2受体结合潜力变化。结果显示两组纹状体ΔBPND随时间恢复至基线的模式无显著差异,提示该成像范式下精神分裂症患者纹状体D2受体内化正常。

要点

  • 精神分裂症患者与健康对照的纹状体D2受体结合潜力恢复至基线的时间过程无显著差异。
  • 诊断分组及分组与时间交互作用对纹状体ΔBPND均无显著影响(F=1.38,P=0.26;F=0.51,P=0.61)。
  • 该PET范式下测得的纹状体D2受体内化在精神分裂症患者中表现正常。

核心结论

  • 精神分裂症患者纹状体D2受体内化在该PET成像范式下与健康对照相似,未见损害。

研究设计与样本

  • 研究纳入10例精神分裂症患者和9例健康对照,采用[11C]raclopride PET在基线及右旋安非他命0.5 mg kg-1后3-5小时和6-10小时进行扫描。

主要发现

  • 诊断分组对纹状体ΔBPND无显著影响(F=1.38,P=0.26)。
  • 诊断分组与安非他命后时间的交互作用对纹状体ΔBPND无显著影响(F=0.51,P=0.61)。

关键数值与推荐

  • 右旋安非他命剂量为0.5 mg kg-1,扫描时间点为基线、给药后3-5小时和6-10小时。
  • 采用线性模型分析ΔBPND,以安非他命后时间为重复测量,时间和诊断分组为固定效应。

临床怎么用

  • 该成像范式下未发现精神分裂症患者纹状体D2受体内化异常,提示D2R内化可能不是该患者群体多巴胺功能障碍的关键环节。

局限性

  • 样本量较小(10例患者和9例对照),可能限制统计效力。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent genetic, molecular and post-mortem studies suggest impaired dopamine (DA)-D2 receptor (D2R) trafficking in patients with schizophrenia (SZ). Imaging and preclinical studies have shown agonist-induced D2R internalization can be imaged with positron emission tomography (PET) using D2R radiotracers combined with psychostimulant challenge. This is feasible if radiotracer binding is measured when postchallenge DA levels have returned to baseline, following the initial competition phase between DA and radiotracer for binding to D2R. Here we used 'late-phase' imaging after challenge to test the hypothesis that impaired D2R internalization in SZ leads to blunted late-phase displacement, or a faster return to baseline, in patients compared with healthy controls (HCs). We imaged 10 patients with SZ and 9 HCs with PET and [11C]raclopride at baseline and two times (3-5 and 6-10 h) following 0.5 mg kg-1 dextroamphetamine. We measured binding potential relative to non-displaceable compartment (BPND) and derived percent reduction from baseline (ΔBPND) for each postamphetamine scan. To test the hypothesis that time course of return of striatal BPND to baseline differed between SZ and HCs, we implemented a linear model with ΔBPND as dependent variable, time after amphetamine as repeated measure and time after amphetamine and diagnostic group as fixed effects. Neither diagnostic group nor interaction of diagnostic group-by-time after amphetamine significantly affected striatal ΔBPND (F=1.38, P=0.26; F=0.51, P=0.61). These results show similar pattern of return of BPND to baseline as a function of time in patients with SZ and HC, suggesting that striatal D2R internalization as measured by our imaging paradigm is normal in patients with SZ.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Weinstein JJ, van de Giessen E, Rosengard RJ, et al. PET imaging of dopamine-D2 receptor internalization in schizophrenia. Mol Psychiatry. 2017. PMID: 28507321. doi:10.1038/mp.2017.107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。